We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKCO
5776
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$10K ﹤0.01%
103
-4
-4% -$442
WKME
5777
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$10K ﹤0.01%
1,000
MRNS
5778
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10K ﹤0.01%
2,070
-290,790
-99% -$1.77M
CBAY
5779
DELISTED
Cymabay Therapeutics
CBAY
$10K ﹤0.01%
3,343
-1,300,368
-100% -$3.11M
TPBAW
5780
DELISTED
TPB Acquisition Corporation I Warrant
TPBAW
0
LGACW
5781
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
0
CLVS
5782
DELISTED
Clovis Oncology, Inc.
CLVS
$10K ﹤0.01%
5,640
-64,132
-92% -$94.6K
AIEQ icon
5783
Amplify AI Powered Equity ETF
AIEQ
$124M
$9K ﹤0.01%
300
-150
-33% -$5.06K
AMCR icon
5784
PUT
Amcor
AMCR
$21.5B
$9K ﹤0.01%
+140
New +$8.66K
DOG
5785
ProShares Short Dow30
DOG
$87.3M
$9K ﹤0.01%
260
-49,840
-99% -$1.72M
FAX
5786
abrdn Asia-Pacific Income Fund
FAX
$604M
$9K ﹤0.01%
+487
New +$9.07K
IMUX icon
5787
Immunic
IMUX
$217M
$9K ﹤0.01%
279
-1,086
-80% -$69.6K
INKM icon
5788
State Street Income Allocation ETF
INKM
$75.3M
$9K ﹤0.01%
283
ORIO
5789
Orion Digital Corp
ORIO
$19.8M
$9K ﹤0.01%
3,333
NOVZ icon
5790
TrueShares Structured Outcome November ETF
NOVZ
$2.63B
$9K ﹤0.01%
+300
New +$9.1K
RPAR icon
5791
RPAR Risk Parity ETF
RPAR
$584M
$9K ﹤0.01%
449
SRRK icon
5792
Scholar Rock
SRRK
$6.55B
$9K ﹤0.01%
1,572
-87,195
-98% -$626K
TALK icon
5793
Talkspace
TALK
$869M
$9K ﹤0.01%
5,000
VMD icon
5794
Viemed Healthcare
VMD
$353M
$9K ﹤0.01%
1,641
-19,633
-92% -$106K
BZAIW
5795
Blaize Holdings Warrants
BZAIW
$6.53M
0
PRLHW
5796
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
0
BFAC.WS
5797
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
0
MIXT
5798
DELISTED
MIX TELEMATICS LIMITED
MIXT
$9K ﹤0.01%
1,101
-44
-4% -$443
IMPL
5799
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$9K ﹤0.01%
1,012
-4,703
-82% -$34.4K
FSTX
5800
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$9K ﹤0.01%
1,498
-19,837
-93% -$66.8K

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.